Explore our media
Learn more about ACTO and the life sciences industry at large through ACTO’s podcast, blogs, events, and more
Featured blogs
Episode 6 | Arif
Why Integrate Coaching and Training for Biopharma Reps?
February 20, 2024
It’s Getting Harder … How Is It Possible?With shrinking access and availability of HCPs and patient safety top of mind, communicating accurate, personalized, and value-driven messages is vital but not always happening. In fact, there are cases where field reps have used unapproved content, including non-MLR approved content, outdated information, even off-label discussions with HCPs. What’s To Be Done?The best
Episode 6 | Arif
Our Learning Journey: What We Learned in 2023; Preparing for 2024
December 19, 2023
As 2023 ends, we are reflecting on the transformative year it has been for Life Sciences as well as for ACTO, and how it will help us enter 2024 with strength and focus for success. 2023 was mostly an uphill battle in Life SciencesThe headwinds continued to blow fiercely in 2023 in Life Sciences: Partnership and innovation were critical to
Pulse is your ultimate source of relevant and innovative strategy
Subscribe today to stay up to date in all thing industry
Subscribe
Recent Articles
Episode 6 | Arif
Why Integrate Coaching and Training for Biopharma Reps?
February 20, 2024
It’s Getting Harder … How Is It Possible?With shrinking access and availability of HCPs and patient safety top of mind, communicating accurate, personalized, and value-driven messages is vital but not always happening. In fact, there are cases where field reps have used unapproved content, including non-MLR approved content, outdated information, even off-label discussions with HCPs. What’s To Be Done?The best
Episode 6 | Arif
Our Learning Journey: What We Learned in 2023; Preparing for 2024
December 19, 2023
As 2023 ends, we are reflecting on the transformative year it has been for Life Sciences as well as for ACTO, and how it will help us enter 2024 with strength and focus for success. 2023 was mostly an uphill battle in Life SciencesThe headwinds continued to blow fiercely in 2023 in Life Sciences: Partnership and innovation were critical to